Plasma corticotropin and cortisol responses to ovine corticotropin- releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 2934-2941

  Dickstein, Gabriel ^a,c   DeBold, C Rowan ^a,d   Gaitan, Daniel ^a,e   Decherney, G Stephen ^a,f   Jackson, Richard V ^a,g   Sheldon Jr , William R ^a,h   Nicholson, Wendell E ^a   Orth, David N ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Haifa Medical Center Rothschild   (Israel)

^d PARK NICOLLET CLINIC   (United States)

^e Barnes West Medical Consultants   (United States)

^f Wilmington Hospital   (United States)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h RHD Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE; METYRAPONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL PROTOCOL; CORTICOTROPIN RELEASE; CORTICOTROPIN TEST; CUSHING DISEASE; DIFFERENTIAL DIAGNOSIS; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPOPHYSIS ADRENAL SYSTEM; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELIABILITY;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; ANIMALS; ARGININE VASOPRESSIN; CHILD; CORTICOTROPIN-RELEASING HORMONE; CUSHING SYNDROME; DRUG SYNERGISM; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PYRIDINES; SHEEP;

OVIS;

EID: 0029830131     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.2934     Document Type: Article

References (58)

1. Orth DN, Kovacs WJ, DeBold CR. 1992 The adrenal cortex. In: Wilson JD, Foster DW (eds) Williams' textbook of endocrinology, 8th ed. Philadelphia: Saunders; 484-619.
2. Aron DC, Tyrrell JB, Fitzgerald PA, Findling JW, Forsham PH. 1981 Cushing's syndrome: problems in diagnosis. Medicine. 60:25-35.
3. Hermus ARMM, Pieters GFFM, Pesman GJ, Smals AGH, Benraad TJ, Kloppenborg PWC. 1987 Enhancement of the ACTH response to human CRH by pretreatment with the antiglucocorticoid RU-486. Eur J Clin Pharmacol. 31:609-611.
4. Grossman AB, Hewlett TA, Perry L, et al. 1988 CRF in the ditferential diagnosis of Cnshing's syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol (Oxf). 29:167-178.
5. Findling JW. 1990 Eutopic or ectopic adrenocorticotropic hormone-dependent Cushing's syndrome? A diagnostic dilemma. Mayo Clin Proc. 65:1377-1380.
6. Liddle GW, Estep HL, Kendall Jr JW, Williams Jr WC, Townes AW. 1959 Clinical application of a new test of pituitary reserve. J Clin Endocrinol Metab. 19:875-894.
7. Sparks LL, Smilo RP, Pavlatos FC, Forsham PH. 1969 Experience with a rapid oral metyrapone test and the plasma ACTH content in determining the cause of Cushing's syndrome Metabolism. 18:175-192.
8. Croughs RJM. 1970 Use of lysin-vasopressin in the differential diagnosis of Cushing's syndrome. Acta Endocrinol (Copenh). 65:595-607.
9. Sindler BH, Griffing GT, Melby JC. 1983 The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome. Am J Med. 74:657-662.
10. Webb-Peploe MM, Spathis GS, Reed PJ. 1967 Cushing's syndrome: use of lysine vasopressin to distinguish overproduction of corticotrophin by pituitary from other causes of adrenal cortical hyperfunction. Lancet. 1:195-197.
11. Tucci JR, Espiner EA, Jagger PI, Lauler DP, Thorn GW. 1968 Vasopressin in the evaluation of pituitary-adrenal function. Ann Intern Med. 69:191-202.
12. Bethge H, Bayer JM, Winkelmann W. 1969 Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocortical adenoma by means of lysine-vasopressin. Acta Endocrinol (Copenh). 60:47-59.
13. Coslovsky R, Wajchenberg BL, Nogueira O. 1974 Hyperresponsiveness to lysine-vasopressin in Cushing's disease. Acta Endocrinol (Copenh). 75:125-132.
14. Krieger DT, Luria M. 1977 Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in Cushing's disease and Nelson's syndrome. J Clin Endocrinol Metab. 44:361-368.
15. Raux MC, Binoux M, Luton J-P, Gourmelen M, Girard F. 1975 Studies of ACTH secretion control in 116 cases of Cushing's syndrome. J Clin Endocrinol Metab. 40: 186-197.
16. Catania A, Cantalamessa I., Orsatti A, et al. 1984 Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the Iysine-vasopressin test. Metabolism. 33:478-481.
17. Kuhn JM, Proeschel MF, Seurin DJ, Bertagna XY, Luton J-P, Girard FL. 1989 Comparative assessment of ACTH and lipotropin plasma levels in the diagnosis and follow-up of patients with Cushing's syndrome: a study of 210 cases. Am J Med. 86:678-684
18. Tabarin A, San Galli F, Dezou S, et al. 1990 corticotropin-releasing factor test in the differential diagnosis of Cushing's syndrome: a comparison with the lysine-vasopressin test. Acta Endocrinol (Copenh). 123:331-338.
19. Orth DN, DeBold CR, DeCherney GS, et al. 1982 Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. J Clin Endocrinol Metab. 55:1117-1019.
20. Pieters GFFM, Hermus ARMM, Smals AGH, Bartelink AK, Benraad TJ, Kloppenborg PWC. 1983 Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab. 57:513-516.
21. Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler Jr GB, Loriaux DL. 1984 The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cnshing's syndrome. N Engl J Med. 310:622-626.
22. Nieman LK, Chrousos GP, Oldfield EH, Avgerinos PC, Cutler Jr GB, Loriaux DL. 1986 The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. Ann Intern Med. 105:862-867.
23. Hermus ARMM, Pieters GFFM, Pesman GJ, Smals AGH, Benraad TJ, Kloppenborg PWC. 1986 Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease. J Clin Endocrinol Metab. 62:634-639.
24. Linn Jr JE, Bowdoin B, Farmer TA, Meador CK. 1967 Observations and comments on failure of dexamethasone suppression. N Engl J Med. 277:403-405.
25. Brown RD, Van Loon GR, Orth DN, Liddle GW. 1973 Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab. 36:445-451.
26. Flack MR, Oldfield EH, Cutler Jr GB, et al. 1992 Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med. 116:211-217.
27. Liu JH, Muse K, Contreras P, et al. 1983 Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor (CKF) by vasopressin in women. J Clin Endocrinol Metab. 57:1087-1089.
28. DeBold CR, Sheldon WR, DeCherney GS, et al. 1984 Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest. 73:533-538.
29. DeBold CR, Jackson RV, Kamilaris TC, et al. 1989 Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man. J Clin Endocrinol Metab. 68:431-437.
30. Liddle GW. 1960 Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab. 20:1539-1560.
31. Oldfield EH, Doppman JL, Nieman LK, et al. 1991 Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med. 325:897-905.
32. DeCherney GS, DeBold CR, Jackson RV, Sheldon Jr WR, Island DP, Orth DN. 1985 Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone. J Clin Endocrinol Metab. 61:273-279.
33. Nicholson WE, Davis DR, Sherrell BJ, Orth DN. 1984 Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin Chem. 30:259-265.
34. Nicholson WE, DeCherney GS, Jackson RV, et al. 1983 Plasma distribution, disappearance halt-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in man. J Clin Endocrinol Metab. 57:1263-1269.
35. Hainsworth JD, Workman R, Greco FA. 1983 Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancer. Cancer 51:161-165.
36. Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler Jr GB. 1993 A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab. 77:1308-1312.
37. Kaye TB, Crapo L. 1990 The Cushing syndrome: an update on diagnostic tests. Ann Intern Med. 112:434-444.
38. Landon J, James VHT, Stoker DJ. 1965 Plasma-cortisol response to lysine-vasopressin. Comparison with other tests of human pituitary-adrenocortical function. Lancet. 2:1156-1169.
39. Hermus ARMM, Pieters GFFM, Smals AGH, Benraad TJ, Kloppenborg PWC. 1984 Plasma adrenocorticotropin, cortisol, and aldosterone responses to corticotropin-releasing factor: modulatory effect of basal cortisol levels. J Clin Endocrinol Metab. 58:187-191.
40. Biller BMK, Alexander JM, Zervas NT, Hedley-Whyte ET, Arnold A, Klibanski A. 1992 Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. J Clin Endocrinol Metab. 75:1303-1309.
41. Jia LG, Canny BJ, Orth DN, Leong DA. 1991 Distinct classes of corticotropes mediate corticotropin-releasing hormone- and arginine vasopressin-stimulated adrenocorticotropin release. Endocrinology. 128:197-203.
42. de Keyzer Y, Auzan C, Lenne F, et al. 1994 Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett. 356:215-220.
43. 3- and CRH receptors in human endocrine tumors. Proc of the 77th Annual Meeting of The Endocrine Soc. 1995;388.
44. Chen R, Lewis KA, Perrin MH, Vale WW. 1993 Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA. 90:8967-8971.
45. Malchoff CD, Orth DN, Abboud C, Carney JA, Pairolero PC, Carey RM. 1988 Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. Am J Med. 84:760-764.
46. Stafford PJ, Kopelman PG, Davidson K, et al. 1989 The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects. Clin Endocrinol (Oxf). 30:661-666.
47. Itoh S, Tanaka K, Kumage M, Shimizu N. 1990 Effects of a long-acting somatostatin analogue on pituitary-adrenocortical secretion in normal human subjects. Endocrinol Jpn. 37:131-139.
48. Invitti C, Pecori Giraldi F, Dubini A, Piolini M, Cavagnini F. 1991 Effect of sandostatin on CRF-stimulated secretion of ACTH, β-lipotropin and β-endorphin. Horm Metab Res. 23:233-235.
49. Suda T, Tomori N, Tozawa F, Demura H, Shizume K. 1984 Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro. J Clin Endocrinol Metab. 59:840-845.
50. 2+ levels by somatostatin in human corticotropin-secreting pituitary adenomas. J Clin Endocrinol Metab. 70:1262-1268.
51. Haslam RJ, Rosson GM. 1972 Aggregation of human blood platelets by vasopressin. Am J Physiol. 223:958-967.
52. Arai K, Takebe K. 1991 Corticotropin response to combined administration of human corticotropin-releasing hormone and small-dose arginine vasopressin in normal subjects. Metabolism. 40:1088-1091.
53. Favrod-Coune C, Raux-Demay MC, Proeschel MF, Bertagna X, Luton J-P. 1993 Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin. Clin Endocrinol (Oxf). 38:405-410.
54. Antoni FA. 1984 Novel ligand specificity of pituitary vasopressin receptors in the rat. Neuroendocrinology. 39:186-188.
55. Gaillard RC, Riondel AM, Ling N, Muller AF. 1988 Corticotropin releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin. Life Sci. 43:1935-1944.
56. Malerbi DA, Mendonca BB, Liberman B, et al. 1993 The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf). 38:463-472.
57. Sederberg-Olsen P, Binder C, Kehlet H, Neville AM, Nielsen LM. 1973 Episodic variation in plasma corticosteroids in subjects with Cushing's syndrome of differing etiology. J Clin Endocrinol Metab. 36:906-910.
58. Horiba N, Suda T, Aiba M, et al. 1995 Lysine vasopressin stimulation of Cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 80:2336-2341.